These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28266048)

  • 1. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
    Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
    Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
    Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
    Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.
    Werner S; Frey S; Riethdorf S; Schulze C; Alawi M; Kling L; Vafaizadeh V; Sauter G; Terracciano L; Schumacher U; Pantel K; Assmann V
    J Biol Chem; 2013 Aug; 288(32):22993-3008. PubMed ID: 23814079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
    Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
    Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
    Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
    Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma.
    Lien HC; Yu HC; Yu WH; Lin SF; Chen TW; Chen IC; Hsiao LP; Yeh LC; Li YC; Lo C; Lu YS
    Breast Cancer Res; 2024 Sep; 26(1):130. PubMed ID: 39256881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.
    Addison JB; Voronkova MA; Fugett JH; Lin CC; Linville NC; Trinh B; Livengood RH; Smolkin MB; Schaller MD; Ruppert JM; Pugacheva EN; Creighton CJ; Ivanov AV
    Mol Cancer Res; 2021 May; 19(5):784-798. PubMed ID: 33500360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
    Sinh ND; Endo K; Miyazawa K; Saitoh M
    Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
    Cieply B; Riley P; Pifer PM; Widmeyer J; Addison JB; Ivanov AV; Denvir J; Frisch SM
    Cancer Res; 2012 May; 72(9):2440-53. PubMed ID: 22379025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.
    Xiang X; Deng Z; Zhuang X; Ju S; Mu J; Jiang H; Zhang L; Yan J; Miller D; Zhang HG
    PLoS One; 2012; 7(12):e50781. PubMed ID: 23284647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRHL2 regulates keratinocyte EMT-MET dynamics and scar formation during cutaneous wound healing.
    Chen T; Zhang B; Xie H; Huang C; Wu Q
    Cell Death Dis; 2024 Oct; 15(10):748. PubMed ID: 39402063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
    Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT-ions with a TWIST between EMT and MET.
    Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
    Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.